Last reviewed · How we verify
picotamide
picotamide is a picotamide drug. It is currently in unknown development.
Picotamide works by inhibiting the action of thromboxane A2, a substance that promotes blood clotting.
Picotamide is a small molecule drug in the picotamide class, originally developed by an unknown entity and currently owned by an unknown entity. Its target and exact mechanism of action are unknown. It is not FDA-approved for any indications. The commercial status of picotamide is unclear, and it is unknown whether it is patented or available as a generic. Key safety considerations are also unknown.
At a glance
| Generic name | picotamide |
|---|---|
| Drug class | picotamide |
| Therapeutic area | Cardiovascular |
| Phase | unknown |
Mechanism of action
Think of it like a traffic jam in your blood vessels. Thromboxane A2 is like a traffic cop that tells your blood vessels to close up and stop blood flow. Picotamide is like a traffic cop that tells the other traffic cop to stand down, keeping your blood vessels open and improving blood flow.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- picotamide CI brief — competitive landscape report
- picotamide updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about picotamide
What is picotamide?
How does picotamide work?
What drug class is picotamide in?
What development phase is picotamide in?
Related
- Drug class: All picotamide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing